Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777021 · ClinicalTrials.gov registry record
Home Away From Home - Quality of Life Surveys
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 154
- Enrollment target
NCT02777021: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT02777021 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02777021 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patients, but there are little clinical data to inform whether management of neutropenia post AML chemotherapy should occur in an outpatient or inpatient setting. Further, no studies have been conducted that assess the impact of neutropenia management strategy on the quality of life of pediatric patients with AML and their caregivers.
Primary Outcome
1 Course of Chemotherapy (Approximately 30-40 days). The primary outcome of interest was patient health-related quality of life (HRQOL) measured using the acute PedsQL™ 4.0 Generic Core Scales.31 These scales use a 7-day time frame. The multidimensional assessment includes items in four domains: physical functioning, emotional functioning, social functioning, and school functioning. Respondents document responses to each question using a 5-point Likert scale anchored by never a problem (0) to al
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-07-18 |
What the finished NCT02777021 record still lists
NCT02777021 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02777021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02777021 about?
NCT02777021 is a clinical study titled "Home Away From Home - Quality of Life Surveys". Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patien...
What is the current status of trial NCT02777021?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2016-09. Estimated completion is 2019-07-18.
Who is sponsoring clinical trial NCT02777021?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia